This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedege, E.
Right arrow Articles by Bjune, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wedege, E.
Right arrow Articles by Bjune, G.

 Previous Article  |  Next Article 

Infect Immun, July 1998, p. 3223-3231, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Immune Responses against Major Outer Membrane Antigens of Neisseria meningitidis in Vaccinees and Controls Who Contracted Meningococcal Disease during the Norwegian Serogroup B Protection Trial

E. Wedege,1,* E. A. Høiby,2 E. Rosenqvist,1 and G. Bjune1

Department of Vaccinology1 and Department of Bacteriology,2 National Institute of Public Health, N-0403 Oslo, Norway

Received 19 September 1997/Returned for modification 8 January 1998/Accepted 22 April 1998

Sera from vaccinees and controls who contracted serogroup B meningococcal disease during the blinded and open parts of a two-dose protection trial in Norway were compared for antigen-specific and bactericidal antibodies against vaccine strain 44/76 (B:15:P1.7,16). From 16 of 20 (80%) vaccinees and 26 of 35 (74%) controls, one or more serum samples (n = 104) were collected during the acute phase (1 to 4 days), early convalescent phase (5 to 79 days), and late convalescent phase (8 to 31 months) after onset of disease. Binding of immunoglobulin G (IgG) to the major outer membrane antigens (80- and 70-kDa proteins, class 1, 3, and 5 proteins, and lipopolysaccharide [LPS]) on immunoblots was measured by digital image analysis. Specific IgG levels in vaccinees increased from acute to early convalescent phases, followed by a decline, while controls showed a small increase over time. Vaccinees had significantly higher levels than controls against class 1 and 3 porins and LPS in acute sera, against all antigens during early convalescence, and against class 1 and 3 porins in the later sera. Vaccinees who were infected with strains expressing subtype P1.7,16 proteins demonstrated a level of IgG binding to protein P1.7,16 with early-convalescent-phase sera that was fourfold higher than that of those infected with other strains. Bactericidal titers in serum against the vaccine strain were 192-fold higher for vaccinees than those for controls during early convalescence, but similarly low levels were found during late convalescence. A vaccine-induced anamnestic response of specific and functional antibody activities was thus shown, but the decrease in protection over time after vaccination indicated that two vaccine doses did not induce sufficient levels of long-term protective antibodies.

* Corresponding author. Mailing address: Department of Vaccinology, National Institute of Public Health, P.O. Box 4404 Torshov, N-0403 Oslo, Norway. Phone: 47 22 04 26 99. Fax: 47 22 04 23 01. E-mail: ewedege{at}online.no.

Infect Immun, July 1998, p. 3223-3231, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Wedege, E., Bergdal, T., Bolstad, K., Caugant, D. A., Efskind, J., Heier, H. E., Kanestrom, A., Strand, B. H., Aaberge, I. S. (2009). Seroepidemiological Study after a Long-Distance Industrial Outbreak of Legionnaires' Disease. CVI 16: 528-534 [Abstract] [Full Text]  
  • Norheim, G., Aseffa, A., Yassin, M. A., Mengistu, G., Kassu, A., Fikremariam, D., Tamire, W., Merid, Y., Hoiby, E. A., Caugant, D. A., Fritzsonn, E., Tangen, T., Melak, B., Berhanu, D., Harboe, M., Kolberg, J., Rosenqvist, E. (2008). Specificity of Subcapsular Antibody Responses in Ethiopian Patients following Disease Caused by Serogroup A Meningococci. CVI 15: 863-871 [Abstract] [Full Text]  
  • Findlow, J., Holland, A., Andrews, N., Weynants, V., Sotolongo, F., Balmer, P., Poolman, J., Borrow, R. (2007). Comparison of Phenotypically Indistinguishable but Geographically Distinct Neisseria meningitidis Group B Isolates in a Serum Bactericidal Antibody Assay. CVI 14: 1451-1457 [Abstract] [Full Text]  
  • Wedege, E., Bolstad, K., Aase, A., Herstad, T. K., McCallum, L., Rosenqvist, E., Oster, P., Martin, D. (2007). Functional and Specific Antibody Responses in Adult Volunteers in New Zealand Who Were Given One of Two Different Meningococcal Serogroup B Outer Membrane Vesicle Vaccines. CVI 14: 830-838 [Abstract] [Full Text]  
  • Norheim, G., Aseffa, A., Yassin, M. A., Mengistu, G., Kassu, A., Fikremariam, D., Tamire, W., Merid, Y., Hoiby, E. A., Caugant, D. A., Fritzsonn, E., Tangen, T., Alebel, T., Berhanu, D., Harboe, M., Rosenqvist, E. (2007). Serum Antibody Responses in Ethiopian Meningitis Patients Infected with Neisseria meningitidis Serogroup A Sequence Type 7. CVI 14: 451-463 [Abstract] [Full Text]  
  • Findlow, J., Taylor, S., Aase, A., Horton, R., Heyderman, R., Southern, J., Andrews, N., Barchha, R., Harrison, E., Lowe, A., Boxer, E., Heaton, C., Balmer, P., Kaczmarski, E., Oster, P., Gorringe, A., Borrow, R., Miller, E. (2006). Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac.. Infect. Immun. 74: 4557-4565 [Abstract] [Full Text]  
  • Feiring, B., Fuglesang, J., Oster, P., Naess, L. M., Helland, O. S., Tilman, S., Rosenqvist, E., Bergsaker, M. A. R., Nokleby, H., Aaberge, I. S. (2006). Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle Vaccine.. CVI 13: 790-796 [Abstract] [Full Text]  
  • Harrison, L. H. (2006). Prospects for Vaccine Prevention of Meningococcal Infection. Clin. Microbiol. Rev. 19: 142-164 [Abstract] [Full Text]  
  • Vidarsson, G., Overbeeke, N., Stemerding, A. M., van den Dobbelsteen, G., van Ulsen, P., van der Ley, P., Kilian, M., van de Winkel, J. G. J. (2005). Working Mechanism of Immunoglobulin A1 (IgA1) Protease: Cleavage of IgA1 Antibody to Neisseria meningitidis PorA Requires De Novo Synthesis of IgA1 Protease. Infect. Immun. 73: 6721-6726 [Abstract] [Full Text]  
  • Toropainen, M., Saarinen, L., Wedege, E., Bolstad, K., Michaelsen, T. E., Aase, A., Kayhty, H. (2005). Protection by Natural Human Immunoglobulin M Antibody to Meningococcal Serogroup B Capsular Polysaccharide in the Infant Rat Protection Assay Is Independent of Complement-Mediated Bacterial Lysis. Infect. Immun. 73: 4694-4703 [Abstract] [Full Text]  
  • Dyet, K. H., Martin, D. R. (2005). Sequence Variation in the porB Gene from B:P1.4 Meningococci Causing New Zealand's Epidemic. J. Clin. Microbiol. 43: 838-842 [Abstract] [Full Text]  
  • Jordens, J. Z., Williams, J. N., Jones, G. R., Christodoulides, M., Heckels, J. E. (2004). Development of Immunity to Serogroup B Meningococci during Carriage of Neisseria meningitidis in a Cohort of University Students. Infect. Immun. 72: 6503-6510 [Abstract] [Full Text]  
  • Urwin, R., Russell, J. E., Thompson, E. A. L., Holmes, E. C., Feavers, I. M., Maiden, M. C. J. (2004). Distribution of Surface Protein Variants among Hyperinvasive Meningococci: Implications for Vaccine Design. Infect. Immun. 72: 5955-5962 [Abstract] [Full Text]  
  • Wedege, E., Kuipers, B., Bolstad, K., van Dijken, H., Froholm, L. O., Vermont, C., Caugant, D. A., van den Dobbelsteen, G. (2003). Antibody Specificities and Effect of Meningococcal Carriage in Icelandic Teenagers Receiving the Norwegian Serogroup B Outer Membrane Vesicle Vaccine. Infect. Immun. 71: 3775-3781 [Abstract] [Full Text]  
  • Thompson, E. A. L., Feavers, I. M., Maiden, M. C. J. (2003). Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149: 1849-1858 [Abstract] [Full Text]  
  • Bhasin, N., Ho, Y., Wetzler, L. M. (2001). Neisseria meningitidis Lipopolysaccharide Modulates the Specific Humoral Immune Response to Neisserial Porins but Has No Effect on Porin-Induced Upregulation of Costimulatory Ligand B7-2. Infect. Immun. 69: 5031-5036 [Abstract] [Full Text]  
  • Moe, G. R., Zuno-Mitchell, P., Lee, S. S., Lucas, A. H., Granoff, D. M. (2001). Functional Activity of Anti-Neisserial Surface Protein A Monoclonal Antibodies against Strains of Neisseria meningitidis Serogroup B. Infect. Immun. 69: 3762-3771 [Abstract] [Full Text]  
  • Tondella, M. L. C., Popovic, T., Rosenstein, N. E., Lake, D. B., Carlone, G. M., Mayer, L. W., Perkins, B. A., The Active Bacterial Core Surveillance Team, (2000). Distribution of Neisseria meningitidis Serogroup B Serosubtypes and Serotypes Circulating in the United States. J. Clin. Microbiol. 38: 3323-3328 [Abstract] [Full Text]  
  • Wedege, E., Caugant, D. A., Musacchio, A., Saunders, N. B., Zollinger, W. D. (1999). Redesignation of a Purported P1.15 Subtype-Specific Meningococcal Monoclonal Antibody as a P1.19-Specific Reagent. CVI 6: 639-642 [Abstract] [Full Text]  
  • Lehmann, A. K., Halstensen, A., Aaberge, I. S., Holst, J., Michaelsen, T. E., Sornes, S., Wetzler, L. M., Guttormsen, H.-K. (1999). Human Opsonins Induced during Meningococcal Disease Recognize Outer Membrane Proteins PorA and PorB. Infect. Immun. 67: 2552-2560 [Abstract] [Full Text]  
  • Oftung, F., Nass, L. M., Wetzler, L. M., Korsvold, G. E., Aase, A., Hoiby, E. A., Dalseg, R., Holst, J., Michaelsen, T. E., Haneberg, B. (1999). Antigen-Specific T-Cell Responses in Humans after Intranasal Immunization with a Meningococcal Serogroup B Outer Membrane Vesicle Vaccine. Infect. Immun. 67: 921-927 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»